Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL (Q57158513)

1

0 references

Hideki Ueno

2

0 references

Casey Glaser

3

0 references

Joseph W. Fay

4

0 references

A. Karolina Palucka

European Journal of Immunology

5

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

0 references

volume

37

0 references

issue

9

0 references

page(s)

2657-2667

0 references

cites work

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

Hyperthermia enhances CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Rational approaches to human cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

The promise of cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

New developments in dendritic cell-based vaccinations: RNA translated into clinics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Dendritic cell based tumor vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Phagocytosis of antigens by Langerhans cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Cutaneous dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021

Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636499

7 January 2021